| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.37 | 0.02 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.02 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |